.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Farmers Insurance
US Army
Argus Health
Merck
Healthtrust
Cantor Fitzgerald
US Department of Justice
Accenture
UBS

Generated: June 27, 2017

DrugPatentWatch Database Preview

PICATO Drug Profile

« Back to Dashboard

Which patents cover Picato, and what generic Picato alternatives are available?

Picato is a drug marketed by Leo Labs and is included in one NDA. There are eleven patents protecting this drug and one Paragraph IV challenge.

This drug has forty-six patent family members in twenty-four countries.

The generic ingredient in PICATO is ingenol mebutate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ingenol mebutate profile page.

Summary for Tradename: PICATO

Patents:11
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list15
Clinical Trials: see list14
Patent Applications: see list24
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PICATO at DailyMed

Pharmacology for Tradename: PICATO

Drug ClassCell Death Inducer
Physiological EffectIncreased Cellular Death
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leo Labs
PICATO
ingenol mebutate
GEL;TOPICAL202833-001Jan 23, 2012RXYesYes8,278,292► SubscribeY ► Subscribe
Leo Labs
PICATO
ingenol mebutate
GEL;TOPICAL202833-002Jan 23, 2012RXYesYes7,410,656► Subscribe ► Subscribe
Leo Labs
PICATO
ingenol mebutate
GEL;TOPICAL202833-002Jan 23, 2012RXYesYes8,536,163► Subscribe ► Subscribe
Leo Labs
PICATO
ingenol mebutate
GEL;TOPICAL202833-001Jan 23, 2012RXYesYes6,432,452► Subscribe ► Subscribe
Leo Labs
PICATO
ingenol mebutate
GEL;TOPICAL202833-001Jan 23, 2012RXYesYes8,372,827► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: PICATO

Drugname Dosage Strength RLD Submissiondate
ingenol mebutateGel0.05%Picato1/27/2016

Non-Orange Book Patents for Tradename: PICATO

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,603,822Therapeutic compositions► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: PICATO

Country Document Number Estimated Expiration
Australia736230► Subscribe
BrazilPI0619919► Subscribe
World Intellectual Property Organization (WIPO)9908994► Subscribe
Denmark1015413► Subscribe
Norway20083150► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: PICATO

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2014030Lithuania► SubscribePRODUCT NAME: INGENOLI MEBUTATUM; REGISTRATION NO/DATE: EU/1/'12/796/001, 2012 11 15 EU/1/12/796/002 20121115
00592Netherlands► SubscribePRODUCT NAME: INGENAN OF EEN DERIVAAT (ZOUT OF ESTER) DAARVAN; REGISTRATION NO/DATE: EU/1/12/796/001-002 20121115
1988877/01Switzerland► SubscribePRODUCT NAME: INGENOLMEBUTAT; REGISTRATION NO/DATE: SWISSMEDIC 62763 12.06.2013
0682Netherlands► SubscribePRODUCT NAME: INGENOLMEBUTAAT OF EEN DERIVAAT (ZOUT OF ESTER) DAARVAN; REGISTRATION NO/DATE: EU/1/12/796 20121119
00682Netherlands► SubscribePRODUCT NAME: INGENOLMEBUTAAT OF EEN DERIVAAT (ZOUT OF ESTER) DAARVAN; REGISTRATION NO/DATE: EU/1/12/796 20121119
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Julphar
Federal Trade Commission
US Department of Justice
Citi
Express Scripts
Boehringer Ingelheim
Queensland Health
Fish and Richardson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot